TransMedics Group, Inc. stock rating and score history
All changes in ratings, performance and outlook tracked over time.
TransMedics Group, Inc. stock price, chart patterns and momentum
Recent price movements, trend behaviour and momentum signals based on real-time market data.
What does TransMedics Group, Inc. do? Business model and key facts
Get the full picture of TransMedics Group, Inc.: what it builds, where it operates, and how it makes money.
Sector: Healthcare
Industry: Medical - Devices
Employees (FY): 728
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
Stocks related to TransMedics Group, Inc.
Selected based on industry alignment and relative market positioning.
Events and news impacting TransMedics Group, Inc. stock
Earnings, coporate decisions and industry developments that can affect the share price.
TransMedics Group, Inc. fundamentals and technical analysis
Financial fundamentals and technicals signals combined to access stability, momentum and market direction.
